MELI three-lens brief
Evidence-based stock research on MELI. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $2439.88 — 30% above current (25 analysts). · Negative free cash flow last quarterly (-$2.46B).
- Analyst mean target $2439.88 — 30% above current (25 analysts).
- Negative free cash flow last quarterly (-$2.46B).
- Debt-to-equity of 169.2 — balance-sheet-heavy.
MELI closed at $1870.14 (+1.09%) as of 2026-05-04. Market cap: $94.81B. P/E (trailing) 47.5. Positives: analyst mean target $2439.88 — 30% above current (25 analysts).. Concerns: negative free cash flow last quarterly (-$2.46B).; debt-to-equity of 169.2 — balance-sheet-heavy.. Last quarter: Revenue $8.76B, net income $559.00M, free cash flow -$2.46B.
Why three lenses on MELI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MELIacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MELI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MELI brief"></iframe>